Applus+ acquires De.Testing, strengthening its global positioning in medical device market

20/01/2025

    Madrid, January 20, 2025. Applus+, a global leader in testing, inspection and certification, has announced the acquisition of De.Testing, a leading medical device testing company based in China. This strategic move strengthens Applus+'s position in the rapidly growing Chinese medical device market and expands its global capabilities in medical device testing. 

    Founded in 2019, De.Testing specializes in medical device testing, with a focus on orthopaedics, dentistry, and medical device software, providing high-quality testing services and customizable technical solutions. De.Testing holds national China Metrology Accreditation (CMA), China National Accreditation Service for Conformity Assessment (CNAS and International Accreditation Service (IAS), international accreditations in the field of medical devices. 

    This acquisition significantly enhances the service offering of Applus+ Laboratories and is key for providing a one-stop-shop solution for clients in the medical device sector, covering a wide range of testing needs. 

    Mauricio Ubeda, Executive Vice President of Applus+ Laboratories, said: "The acquisition of De.Testing strengthen our global position in medical device testing. Their impressive range of services, from biomechanical to cybersecurity and active medical device testing, coupled with their national and international accreditations, significantly enhances our capabilities. De.Testing's expertise and strong team perfectly complements our existing services and will be invaluable as we continue to expand our offerings in key markets." 

    Paul Cai, CEO of De.Testing, commented: "Joining forces with Applus+ opens up exciting new opportunities for De.Testing. Our shared commitment to quality, innovation, and customer service makes this a perfect match. As part of the Applus+ family, we look forward to leveraging our combined expertise, expanding our services, and contributing to the advancement of medical device testing and certification on a global scale." 

    About the Applus+ Group 

    Applus+ is one of the world's leading companies in the testing, inspection, and certification sector. We are a trusted partner that helps clients enhance the quality and safety of their assets and operations while safeguarding their environmental performance. Our technical capabilities, innovation, and highly qualified team of more than 26,000 professionals allow us to ensure operational excellence across a wide range of sectors in over 65 countries. 

    We offer a comprehensive portfolio of solutions to meet a variety of needs, from asset management to regulatory inspections. At Applus+, we maintain a strong commitment to technological development, digitalisation, and the constant improvement of our knowledge of standards and regulatory requirements. 

    Applus+ uses first-party and third-party cookies for analytical purposes and to show you personalized advertising based on a profile drawn up based on your browsing habits (eg. visited websites). You can accept all cookies by pressing the "Accept" button or configure or reject their use. Consult our Cookies Policy for more information.

    Cookie settings panel